Regulation of lupus pathogenesis through modulation of thymic development of pathobiont-specific T cells

通过调节病原体特异性 T 细胞的胸腺发育来调节狼疮发病机制

基本信息

项目摘要

PROJECT SUMMARY/ABSTRACT CANDIDATE: I am a postdoctoral research associate in the laboratory of Dr. Gretchen E. Diehl in the Immunology Program at Memorial Sloan-Kettering Cancer Center. I obtained my PhD working in gut microbiota and systemic lupus erythematosus under the supervision of Dr. Martin Kriegel. My current research applies the techniques I learned in my postdoc and graduate school to assess the role of gut microbes in the thymic development of microbiota-specific T cells and how these T cells can modulate disease in susceptible hosts. To elucidate this process, I used a tetramer-based approach to identify and track antigen-specific T cells expansion in the thymus before they distribute and differentiate in the periphery. I plan to study how this process is altered in autoimmunity. My proposed research and mentoring plan will provide me the required foundation to transition into an independent researcher with a long-term career goal to understand how microbiota-specific T cell responses arise and define how they exacerbate lupus pathogenesis. To achieve this goal, together with my mentoring team, I have developed a career plan that will 1) increase my technical skills, 2) refine my scientific scope, 3) improve my communication skills, and 4) expand my scientific network. RESEARCH: Lupus development is associated with intestinal dysbiosis in patients and mouse models. Dysbiosis in lupus is characterized by pathobiont overgrowth and is linked to dysregulated immune responses that exacerbate pathogenesis. In my graduate work, I found increased pathobionts including Lactobacillus reuteri in mouse lupus models and subsets of SLE patients. I showed L. reuteri translocated systemically, leading to increased inflammatory pathways and proinflammatory T cells which exacerbated systemic inflammation and worsened lupus pathogenesis. In my postdoctoral work, I am investigating how differentiation of microbiota-specific T cells is regulated during development and its effects in inflammatory processes. While we and others find peripheral expansion of microbiota-specific T cells with effector function in adult mice, in young mice we surprisingly found microbiota-specific T cells first expanded in the thymus, a site not previously known to allow for antigen-specific T cell expansion. I aim to synergize the knowledge generated during my graduate and postdoctoral training to determine if thymic development of L. reuteri-specific T cells is amplified in lupus susceptible hosts and to assess their role in lupus exacerbation. I will develop this proposal by 1) Determining how thymic microbiota-specific T cells modulate lupus pathogenesis and 2) Defining how lupus pathobionts modulate pathobiont-specific T cells expansion. ENVIRONMENT: The laboratory is part of the Immunology program at Memorial Sloan-Kettering Cancer Center, a state-of-the-art research institute. Furthermore, my mentoring committee and collaborators will provide the required scientific and non-scientific support for the research and career development proposed.
项目概要/摘要 候选人:我是 Gretchen E. Diehl 博士实验室的博士后研究员 纪念斯隆-凯特琳癌症中心的免疫学项目。我在肠道工作中获得了博士学位 在 Martin Kriegel 博士的监督下研究微生物群和系统性红斑狼疮。我目前的研究 应用我在博士后和研究生院学到的技术来评估肠道微生物在 微生物群特异性 T 细胞的胸腺发育以及这些 T 细胞如何调节易感人群的疾病 主机。为了阐明这个过程,我使用了基于四聚体的方法来识别和跟踪抗原特异性 T 细胞 在胸腺中扩张,然后在周围分布和分化。我打算研究一下如何 自身免疫过程发生改变。我提出的研究和指导计划将为我提供所需的 为转变为具有长期职业目标的独立研究人员奠定基础,以了解如何 微生物群特异性 T 细胞反应的出现并决定了它们如何加剧狼疮发病机制。为了实现这一目标 为了实现这一目标,我与我的指导团队一起制定了职业计划,该计划将 1)提高我的技术技能, 2) 完善我的科学范围,3) 提高我的沟通技巧,4) 扩大我的科学网络。 研究:狼疮的发展与患者和小鼠模型的肠道菌群失调有关。 狼疮的生态失调的特点是病原体过度生长,并与免疫反应失调有关 从而加剧发病。在我的研究生工作中,我发现包括乳酸菌在内的病原体有所增加 小鼠狼疮模型和 SLE 患者亚群中的罗伊氏菌。我展示了罗伊氏乳杆菌的系统易位, 导致炎症途径和促炎性 T 细胞增加,从而加剧全身性炎症 炎症和狼疮发病机制恶化。在我的博士后工作中,我正在研究分化如何 微生物群特异性 T 细胞在发育过程中受到调节及其对炎症过程的影响。尽管 我们和其他人发现成年小鼠中具有效应功能的微生物群特异性 T 细胞的外周扩张 在年轻小鼠中,我们令人惊讶地发现微生物群特异性 T 细胞首先在胸腺中扩增,这是一个以前从未出现过的部位 已知允许抗原特异性 T 细胞扩增。我的目标是整合我在大学期间获得的知识 研究生和博士后培训以确定罗伊氏乳杆菌特异性 T 细胞的胸腺发育是否得到放大 狼疮易感宿主并评估其在狼疮恶化中的作用。我将通过 1) 制定此提案 确定胸腺微生物群特异性 T 细胞如何调节狼疮发病机制以及 2) 定义狼疮如何 Pathobionts 调节 Pathobiont 特异性 T 细胞的扩增。 环境:该实验室是纪念斯隆-凯特琳癌症中心免疫学项目的一部分 中心,一个最先进的研究机构。此外,我的指导委员会和合作者将 为拟议的研究和职业发展提供所需的科学和非科学支持。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Daniel Fernando Zegarra Ruiz其他文献

Daniel Fernando Zegarra Ruiz的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Daniel Fernando Zegarra Ruiz', 18)}}的其他基金

Regulation of lupus pathogenesis through modulation of thymic development of pathobiont-specific T cells
通过调节病原体特异性 T 细胞的胸腺发育来调节狼疮发病机制
  • 批准号:
    10525740
  • 财政年份:
    2022
  • 资助金额:
    $ 9.19万
  • 项目类别:

相似国自然基金

Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
  • 批准号:
    2022J011295
  • 批准年份:
    2022
  • 资助金额:
    10.0 万元
  • 项目类别:
    省市级项目
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
  • 批准号:
    30801055
  • 批准年份:
    2008
  • 资助金额:
    19.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Bovine herpesvirus 4 as a vaccine platform for African swine fever virus antigens in pigs
牛疱疹病毒 4 作为猪非洲猪瘟病毒抗原的疫苗平台
  • 批准号:
    BB/Y006224/1
  • 财政年份:
    2024
  • 资助金额:
    $ 9.19万
  • 项目类别:
    Research Grant
Uncovering tumor specific antigens and vulnerabilities in ETP-acute lymphoblastic leukemia
揭示 ETP-急性淋巴细胞白血病的肿瘤特异性抗原和脆弱性
  • 批准号:
    480030
  • 财政年份:
    2023
  • 资助金额:
    $ 9.19万
  • 项目类别:
    Operating Grants
A novel vaccine approach combining mosquito salivary antigens and viral antigens to protect against Zika, chikungunya and other arboviral infections.
一种结合蚊子唾液抗原和病毒抗原的新型疫苗方法,可预防寨卡病毒、基孔肯雅热和其他虫媒病毒感染。
  • 批准号:
    10083718
  • 财政年份:
    2023
  • 资助金额:
    $ 9.19万
  • 项目类别:
    Small Business Research Initiative
Regulation of B cell responses to vaccines by long-term retention of antigens in germinal centres
通过在生发中心长期保留抗原来调节 B 细胞对疫苗的反应
  • 批准号:
    MR/X009254/1
  • 财政年份:
    2023
  • 资助金额:
    $ 9.19万
  • 项目类别:
    Research Grant
Adaptive Discrimination of Risk of Antigens in Immune Memory Dynamics
免疫记忆动态中抗原风险的适应性辨别
  • 批准号:
    22KJ1758
  • 财政年份:
    2023
  • 资助金额:
    $ 9.19万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
22-ICRAD Call 2 - Improving the diagnosis of tuberculosis in domestic ruminants through the use of new antigens and test platforms
22-ICRAD 呼吁 2 - 通过使用新抗原和测试平台改善家养反刍动物结核病的诊断
  • 批准号:
    BB/Y000927/1
  • 财政年份:
    2023
  • 资助金额:
    $ 9.19万
  • 项目类别:
    Research Grant
Protective immunity elicited by distinct polysaccharide antigens of classical and hypervirulent Klebsiella
经典和高毒力克雷伯氏菌的不同多糖抗原引发的保护性免疫
  • 批准号:
    10795212
  • 财政年份:
    2023
  • 资助金额:
    $ 9.19万
  • 项目类别:
Integrative proteome analysis to harness humoral immune response against tumor antigens
综合蛋白质组分析利用针对肿瘤抗原的体液免疫反应
  • 批准号:
    23K18249
  • 财政年份:
    2023
  • 资助金额:
    $ 9.19万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Functionally distinct human CD4 T cell responses to novel evolutionarily selected M. tuberculosis antigens
功能独特的人类 CD4 T 细胞对新型进化选择的结核分枝杆菌抗原的反应
  • 批准号:
    10735075
  • 财政年份:
    2023
  • 资助金额:
    $ 9.19万
  • 项目类别:
Targeting T3SA proteins as protective antigens against Yersinia
将 T3SA 蛋白作为针对耶尔森氏菌的保护性抗原
  • 批准号:
    10645989
  • 财政年份:
    2023
  • 资助金额:
    $ 9.19万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了